User profiles for "author:Massimo Filippi"
Massimo FilippiSan Raffaele Scientific Institute, Vita-Salute San Raffaele University Verified email at hsr.it Cited by 128393 |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof… - The Lancet …, 2018 - thelancet.com
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in
research and clinical practice. Scientific advances in the past 7 years suggest that they might …
research and clinical practice. Scientific advances in the past 7 years suggest that they might …
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
CH Polman, SC Reingold, G Edan… - Annals of Neurology …, 2005 - Wiley Online Library
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image
assessment with clinical and other paraclinical methods were introduced in 2001. The …
assessment with clinical and other paraclinical methods were introduced in 2001. The …
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
We compared MRI criteria used to predict conversion of suspected multiple sclerosis to
clinically definite multiple sclerosis. Seventy-four patients with clinically isolated neurological …
clinically definite multiple sclerosis. Seventy-four patients with clinically isolated neurological …
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell… - Annals of …, 2011 - Wiley Online Library
New evidence and consensus has led to further revision of the McDonald Criteria for
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
Background Interferon beta reduces activity in multiple sclerosis as measured clinically and
by magnetic resonance imaging (MRI). We assessed the effect of interferon beta-1a on the …
by magnetic resonance imaging (MRI). We assessed the effect of interferon beta-1a on the …
European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured …
G Comi, M Filippi, JS Wolinsky… - Annals of …, 2001 - Wiley Online Library
Two prior double‐blind, placebo‐controlled, randomized trials demonstrated that glatiramer
acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis …
acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis …
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
In patients presenting with a clinically isolated syndrome, MRI can support and substitute
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination …
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination …
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
MP Wattjes, O Ciccarelli, DS Reich, B Banwell… - The Lancet …, 2021 - thelancet.com
Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
In 85% of young adults with multiple sclerosis (MS), onset is a subacute clinically isolated
syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the …
syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the …
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of
diseases that could better explain the clinical and paraclinical findings. A systematic process …
diseases that could better explain the clinical and paraclinical findings. A systematic process …